First psychedelic healthcare fund launched in the UK

The UK’s first investment fund dedicated to psychedelic healthcare has been launched. Neo Kuma Ventures, founded in 2019, launched the fund to invest in medicines to treat illnesses including depression, anxiety and addiction. The firm hopes to make Europe a ‘new hub’ for psychedelic healthcare.